GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Related Posts
Fang D, McWIlliams J, Wang C, Maziero D, Iwamoto KS, Kishan AU, Finn JP, Zhong X, Ruan D. In-Depth optimization and characterization of prostatic and[...]
Zhang Y, Siu KL, Huang K, Huang Y, Cai H. Attenuation of advanced atherosclerosis and aortic aneurysm in hph-1/apoE DKO mice by folic acid and[...]
Miyazaki K, Olivas JA, Miyazaki Y, Sato T, Rimmer M, Moussa ID, Fishbein MC, Shivkumar K, Mori S. Impinged and Disrupted Left Bundle Branch by[...]